# Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

> **NCT01249053** · — · UNKNOWN · sponsor: **China Medical University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Lung Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01249053
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01249053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01249053, "Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01249053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*